| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,009 | 4,672 | 4,395 | 6,830 | | Cost of Revenue | 3,577 | 3,256 | 3,592 | 4,983 | | | Gross Profit | 2,432 | 1,416 | 803 | 1,847 | | | Operating Expenses | | Research Development | 515 | 576 | 757 | 1,002 | | Selling General and Administrative | 2,149 | 2,410 | 2,821 | 3,719 | | Non Recurring | 27 | 269 | 60 | 1,830 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (259) | (1,839) | (2,835) | (4,704) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2 | (104) | 98 | 213 | | Earnings Before Interest And Taxes | (257) | (1,943) | (2,737) | (4,491) | | Interest Expense | 20 | 17 | 17 | 20 | | Income Before Tax | (277) | (1,960) | (2,754) | (4,511) | | Income Tax Expense | 1 | (8) | 1 | (93) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (278) | (1,952) | (2,755) | (4,418) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (278) | (1,952) | (2,755) | (4,418) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($278) | ($1,952) | ($2,755) | ($4,418) |
|
0.51% Nasdaq 
Income Statement
